305 377

Cited 35 times in

Effect of probiotic Lactobacillus (Lacidofil® cap) for the prevention of antibiotic-associated diarrhea: a prospective, randomized, double-blind, multicenter study.

Authors
Song, HJ; Kim, JY; Jung, SA; Kim, SE; Park, HS; Jeong, Y; Hong, SP; Cheon, JH; Kim, WH; Kim, HJ; Ye, BD; Yang, SK; Kim, SW; Shin, SJ; Kim, HS; Sung, JK; Kim, EY
Citation
Journal of Korean medical science, 25(12):1784-1791, 2010
Journal Title
Journal of Korean medical science
ISSN
1011-89341598-6357
Abstract
Antibiotic-associated diarrhea (AAD) is a common complication of antibiotic use. There is growing interest in probiotics for the treatment of AAD and Clostridium difficile infection because of the wide availability of probiotics. The aim of this multicenter, randomized, placebo-controlled, double-blind trial was to assess the efficacy of probiotic Lactobacillus (Lacidofil® cap) for the prevention of AAD in adults. From September 2008 to November 2009, a total of 214 patients with respiratory tract infection who had begun receiving antibiotics were randomized to receive Lactobacillus (Lacidofil® cap) or placebo for 14 days. Patients recorded bowel frequency and stool consistency daily for 14 days. The primary outcome was the proportion of patients who developed AAD within 14 days of enrollment. AAD developed in 4 (3.9%) of 103 patients in the Lactobacillus group and in 8 (7.2%) of 111 patients in the placebo group (P=0.44). However, the Lactobacillus group showed lower change in bowel frequency and consistency (50/103, 48.5%) than the placebo group (35/111, 31.5%) (P=0.01). Although the Lacidofil® cap does not reduce the rate of occurrence of AAD in adult patients with respiratory tract infection who have taken antibiotics, the Lactobacillus group maintains their bowel habits to a greater extent than the placebo group.
MeSH terms
AdultAgedAnti-Bacterial Agents/*adverse effects/therapeutic useDiarrhea/chemically induced/*prevention & controlDouble-Blind MethodFemaleHumans*LactobacillusMaleMiddle AgedOdds RatioProbiotics/*therapeutic useProspective StudiesRespiratory Tract Infections/drug therapyRisk Factors
DOI
10.3346/jkms.2010.25.12.1784
PMID
21165295
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Gastroenterology
AJOU Authors
신성재
Full Text Link
Files in This Item:
jkms-25-1784-1791.pdfDownload
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse